Relmada Therapeutics Inc. (RLMD)

AI Score

Unlock

0.26

-0.02 (-5.76%)

At close: Apr 04, 2025, 10:19 AM

Relmada Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Aug 31, 2013	Aug 31, 2012
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.13K	7.94K
Cost of Revenue	n/a	n/a	n/a	1.26K	3.75K	n/a	4.87K	2.63K	85.27K	54.82K	9.26K	4.04K	5.8K
Gross Profit	n/a	n/a	n/a	-1.26K	-3.75K	n/a	-4.87K	-2.63K	-85.27K	-54.82K	-9.26K	1.09K	2.14K
Operating Income	n/a	-103.7M	-161.25M	-125.7M	-60.84M	-15.11M	-12.73M	-6.92M	-7.22M	-16.22M	-17.1M	-45.02K	-12.05K
Interest Income	n/a	n/a	2.66M	1.2M	1.4M	104.11	-761.04K	n/a	n/a	1.75K	10.88K	n/a	n/a
Pretax Income	n/a	-98.79M	-157.04M	-125.75M	-59.46M	-15.01M	-17.32M	-8.96M	-6.29M	-2.97M	-20.8M	-45.02K	-12.05K
Net Income	n/a	-98.79M	-157.04M	-125.75M	-59.46M	-15.01M	-17.32M	-8.96M	-6.29M	-2.97M	-20.8M	-45.02K	-12.05K
Selling & General & Admin	24.25M	48.89M	47.93M	35.08M	24.87M	7.25M	5.7M	3.97M	5.93M	10.01M	9.23M	46.11K	13.82K
Research & Development	5.93M	54.81M	113.32M	90.62M	35.97M	7.86M	7.02M	2.94M	1.29M	6.21M	7.87M	5.38M	n/a
Other Expenses	n/a	-293	6.35M	n/a	n/a	n/a	n/a	2.35K	216.21K	130.27K	n/a	n/a	n/a
Operating Expenses	30.18M	103.7M	161.25M	125.7M	60.84M	15.11M	12.73M	6.92M	7.22M	16.22M	17.1M	46.11K	13.82K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.34M	550.00	n/a	4.92K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03K	4.73K
Cost & Expenses	n/a	103.7M	161.25M	125.7M	60.84M	15.11M	12.73M	6.92M	7.22M	16.22M	17.1M	50.14K	19.62K
Income Tax Expense	n/a	n/a	-2.66M	48.32K	-1.38M	-1	4.59M	2.05M	-716.1K	-13.11M	3.7M	-9.58M	-377
Shares Outstanding (Basic)	30.17M	30.1M	29.63M	17.55M	15.59M	9.23M	6.31M	3.14M	3.02M	2.9M	2.49M	1.43M	1.43M
Shares Outstanding (Diluted)	30.17M	30.1M	29.63M	17.55M	15.59M	9.23M	6.31M	3.14M	3.02M	2.9M	2.49M	1.43M	1.43M
EPS (Basic)	n/a	-3.28	-5.3	-7.16	-3.81	-1.63	-2.74	-2.86	-2.08	-1.03	-8.37	-0.03	-0.01
EPS (Diluted)	n/a	-3.28	-5.3	-7.16	-3.81	-1.63	-2.74	-2.86	-2.08	-1.03	-8.37	-0.03	-0.01
EBITDA	n/a	4.91M	-157.04M	-125.75M	-59.45M	-15.1M	-16.55M	-6.91M	-6.92M	-16.03M	-17.09M	-45.02K	-11.68K
EBIT	n/a	-98.79M	-157.04M	-125.75M	-59.46M	-15.11M	-16.56M	-6.92M	-7.01M	-16.09M	-17.1M	-45.02K	-11.68K
Depreciation & Amortization	n/a	103.7M	2K	1.26K	3.75K	4.36K	4.87K	2.63K	85.27K	54.82K	9.26K	250.00	754.00